Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/2003
10/09/2003WO2001085917A3 A device
10/09/2003US20030191349 Process for the preparation of phenylphenol compounds
10/09/2003US20030191311 Imidazole derivatives
10/09/2003US20030191291 Synthetic erythropoiesis stimulating proteins
10/09/2003US20030191285 Novel g protein-coupled receptor proteins and dnas thereof
10/09/2003US20030191192 Aqueous suspension of drug; storage stability
10/09/2003US20030191184 Antiinflammatory agents; prevent boactericide diffusion; using fatty acids
10/09/2003US20030191181 4-[(8-Ethynyl, 8-vinyl or 8-ethynyl-methyl)-6-chromanoyl]-benzoic and 2-[4-[(8-ethynyl, 8-vinyl or 8-ethynyl-methyl)-6-chromanoyl]-phenyl]-acetic acid, their esters and salts having cytochrome P450RAI inhibitory activity
10/09/2003US20030191180 Pharmaceutical compositions
10/09/2003US20030191177 Maintenance dosage of beta blocker; cardiovascular disorders
10/09/2003US20030191175 Indole sPLA2 inhibitors
10/09/2003US20030191169 Methods for increasing the survival of aquatic and other animals exposed to an aquatic virus, birnavirus or other RNA virus and compositions for such methods
10/09/2003US20030191160 Aids therapy; calibration efficiency of benzimidazole compound
10/09/2003US20030191157 Injections
10/09/2003US20030191113 For agriculture
10/09/2003US20030191108 N-thiolated beta-lactams: novel antibacterial agents for methicillin-resistant staphylococcus aureus
10/09/2003US20030191105 7-acylamino-3-(imino)methyl cephalosporins; 7-[[(5-Amino-1,2,4-thiadiazol-3-yl)-(Z)-(fluormethoxyimino)acetyl]amino]-3-[[(piperazinoiminomethyl)hydrazono]methyl]-3-cephem-4-carboxylic acid; imination of 3-methyl derivative; acylation at the 7-amino; 1-[hydrazino(methylimino)methyl]piperazine intermediate
10/09/2003US20030191103 Hormone replacement therapy
10/09/2003US20030191098 Synergistic mixture of thalidomide antiinflammatory agnets
10/09/2003US20030191097 Hormone replacement therapy
10/09/2003US20030191092 MMP inhibitors
10/09/2003US20030191086 Substituted nitrogen heterocyclic derivatives and pharmaceutical use thereof
10/09/2003US20030191082 Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines
10/09/2003US20030191079 Methods for treating and preventing infectious disease
10/09/2003US20030191074 Antibody therapy; immobilization
10/09/2003US20030191067 Hepatitis C inhibitor tri-peptides
10/09/2003US20030191065 Insulin-like growth factor; genetic engineering; central nervous system disorders
10/09/2003US20030191057 Cardiovascular disorders; antiinflammatory agents
10/09/2003US20030191052 Infection therapy; binding of mannan lecithin to protein
10/09/2003US20030191051 Combination therapy for the treatment of bacterial infections
10/09/2003US20030191048 Gene expression profile for KSHV infection and methods for treating same
10/09/2003US20030190732 Plasma fraction containing bikunin, method for the production thereof and use of the same
10/09/2003US20030190685 Bind to Tumor Necrosis Factor(TNF)-Related Apoptosis Inducing Ligand (TRAIL) receptors ; used in the prevention and treatment of cancers and other proliferative disorders
10/09/2003US20030190676 In which covalently modified antibody takes on the binding specificity of a targeting agent
10/09/2003US20030190642 Thymus expressed human cytochrome p450(p450tec)
10/09/2003US20030190613 Polynucleotide encoding an activated human T-lymphocyte-derived protein related to ubiquitin conjugating enzyme
10/09/2003US20030190607 Polymorphisms in human pyruvate dehydrogenase E1 beta (PDH E1 beta) gene; for analysing allelic variation; bioinformatic applications
10/09/2003US20030190606 Hepatitis C virus NS5B truncated protein and methods thereof to identify antiviral compounds
10/09/2003US20030190365 Mixing non-dihydrate azithromycin particles with granulating amount of granulating liquid and optionally excipients to form wet granules which comprise non-dihydrate azithromycin and the granulating liquid
10/09/2003US20030190340 Gel formulations of 1-hydroxy-2(H)pyridone derivatives, which contain solvents and hydrophilic gel-forming agents
10/09/2003US20030190334 1S-(1 alpha ,3 alpha ,4 beta ))-2-amino-1,9-dihydro-9-(4-hydroxy-3-(hydroxymethyl)-2 -methylenecyclopentyl)-6H-puri n-6-one to treat hepatitis B virus infection
10/09/2003US20030190332 Engineered viral particle containing a group of co-expressed viral proteins or portions expressed in an edible plant material, adminstering such plant material containing viral vaccine to the gastrointenial mucosa of the patient
10/09/2003US20030190331 Vaccine composition and stabilisation method
10/09/2003US20030190330 Recombinant canine distemper virus vaccine against canine distemper and leishmaniasis
10/09/2003US20030190328 Immuno-reactive peptide CTL epitopes of human cytomegalovirus
10/09/2003US20030190326 Pharmaceutical composition for immunisation against aids
10/09/2003US20030190324 Immunologically significant herpes simplex virus antigens and methods for using same
10/09/2003US20030190311 Immunoglobulins; fusion proteins; vaccines
10/09/2003US20030190309 Novel probiotics for pet food applications
10/09/2003US20030190306 HLA matching donor-originating activated lymphocytes to be used in prevention/treatment of tumors, infectious diseases and autoimmune diseases, treatment method achieved by using the lymphocytes, formula having the lymphocytes as a main constituent thereof, method for manufacturing the formula and preparation kit to be used to prepare the formula
10/09/2003US20030188740 Method for production of enhanced traceable immunizing drinking water and other liquid and gas products, devices for production and use thereof, and use of the enhanced products for immunizing living beings
10/09/2003CA2481795A1 Use of topoisomerase inhibitors and heat shock protein 90 inhibitors for use in chemotherapy
10/09/2003CA2481232A1 Replikin peptides in rapid replication of glioma cells and in influenza epidemics
10/09/2003CA2480888A1 New aryl imidazoles and related compounds as c5a receptor modulators
10/09/2003CA2480857A1 Improvements in pharmaceutical compositions
10/09/2003CA2480694A1 Ox40r binding agents
10/09/2003CA2480568A1 Thiazol-2-yl-imine compounds as pde-7 inhibitors
10/09/2003CA2480372A1 Combination therapy using trefoil peptides
10/09/2003CA2480317A1 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders
10/09/2003CA2480265A1 Cochleates made with purified soy phosphatidylserine
10/09/2003CA2480227A1 Neuroprotectant methods, compositions, and screening methods thereof
10/09/2003CA2480141A1 Oxygenating agents for enhancing host responses to microbial infections
10/09/2003CA2480128A1 Methods of using flt3-ligand in immunization protocols
10/09/2003CA2479807A1 Antimicrobial polymer conjugates
10/09/2003CA2479205A1 Azaindoles as inhibitors of c-jun n-terminal kinases
10/09/2003CA2478502A1 Novel antiinfective compounds, process for their preparation and pharmaceutical compositions containing them
10/09/2003CA2478470A1 Solubilization of weak bases
10/09/2003CA2477764A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
10/09/2003CA2477734A1 Suramin and derivatives thereof as topical microbicide and contraceptive
10/09/2003CA2475202A1 Use of non-antibacterial tetracycline analogs and formulations thereof for the treatment of bacterial exotoxins
10/09/2003CA2469720A1 Truncated lysostaphin molecule with enhanced staphylolytic activity
10/09/2003CA2448540A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/08/2003EP1350848A2 T-cell membrane protein (TIRC7), gene encoding it and antibodies against it and uses thereof
10/08/2003EP1350840A1 Adaptation sites of PRRSV
10/08/2003EP1350519A1 Drugs and foods improving the quality of life and process for producing the same
10/08/2003EP1350510A1 Use of agent for suppressing infection and proliferation of human immunodeficiency syndrome virus
10/08/2003EP1350508A1 Antifungal formulation and the methods for manufacturing and using the same
10/08/2003EP1350113A2 Inhibition of cmv infection and dissemination
10/08/2003EP1349963A2 Method for the determination of at least one functional polymorphism in the nucleotide sequence of a preselected candidate gene and its applications
10/08/2003EP1349936A2 Regulation of human b7-h2 protein
10/08/2003EP1349920A2 Adenylate cyclases
10/08/2003EP1349874A2 Peptide and polypeptide inhibitors of complement c1s
10/08/2003EP1349873A2 Modulation of il-2- and il-15-mediated t cell responses
10/08/2003EP1349853A2 Antimicrobial quinolone derivatives and use of the same to treat bacterial infections
10/08/2003EP1349852A2 4-(hetero)aryl substituted indolinones
10/08/2003EP1349842A1 1-dimercaptoalkylquinazolin-2,4(1h,3h)-diones as matrix metalloproteinase (mmp) inhibitors
10/08/2003EP1349841A2 Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto
10/08/2003EP1349840A2 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto
10/08/2003EP1349839A1 Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists
10/08/2003EP1349836A2 Tetracyclic derivatives as spla2 inhibitors
10/08/2003EP1349834A2 Cycloalkyfused [g]-indole compounds as spla2-inhibitors in the treatment of inflammatory diseases
10/08/2003EP1349833A1 Indole and dihydroindole derivatives
10/08/2003EP1349832A2 Substituted benzoindoles as spla2 inhibitors
10/08/2003EP1349577A2 Intracellular delivery of charged therapeutic moieties to nerve cells by means of targeting proteins
10/08/2003EP1349570A1 ENTEROHEMORRAGIC i ESCHERICHIA COLI /i VACCINE
10/08/2003EP1349568A1 Immunomodulatory constructs and their uses
10/08/2003EP1349562A2 Inhibiting gs-fdh to modulate no bioactivity
10/08/2003EP1349561A2 Local use of essential oils for treating herpes labialis
10/08/2003EP1349558A1 Composition comprising melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity
10/08/2003EP1349553A1 Dihydro-triterpenes in the treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain
1 ... 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 ... 1798